Topic Listing for Immucor

A-quantitative Qualitative Disclosures Market Risk Abs2000
Abs2000 Generation Blood Bank System Absence Certain Changes Events
Absence Undisclosed Liabilities Absence Violations Conflicts
Acceleration Vesting Certain Option Acceleration Vesting Certain Options
Accounting Asset Retirement Obligations Accounting Changes Error Corrections
Accounting Conditional Asset Retirement Obligations-an Interpretation Fasb Statement Accounting Contingencies
Accounting Derivative Instruments Hedging Activities Accounting Impairment Long-lived Assets Disposed
Accounting Income Taxes Accounting Nonmonetary Transactions
Accounting Revenue Arrangements Multiple Deliverables Accounting Stock Issued Employees
Accounting Stock-based Compensation Accounting Stock-based Compensation Transition Disclosure
Accounting Stock-based Compensation Transition Disclosure Amendment Fasb Statement Accounts Receivable Trade
Accruals Funding Acquisition
Acquisition Japan Action Directors Without Meeting
Action Shareholders Without Meeting Additional Indemnification
Additional Solid Phase Applications Adjournments
Adjustments Aggregate Merger Consideration Administration
Adopted 2009 Adopted 2010
Adopted Pursuant 906 Sarbanes-oxley Act 2002 Advance Payments Research Development Activities
Advances Advertising Costs
Advertising Costs- Affiliate
Agreement Agreement Plan Merger
Agreements Alignment Historical Results Bioarray Immucors
Allowance Doubtful Accounts Amended Restated Employment Agreement
Amended Restated Fifth Amendment Office Lease Agreement Amendment
Amendment Amended Restated Shareholder Rights Agreement Amendment Lease
Amendments Annual Cash Incentives Bonuses
Annual Meeting Shareholders Held 2005 Annual Meeting Shareholders Held 2006
Annual Meeting Shareholders Held 2007 Annual Meeting Shareholders Immucor Inc Held 2005
Annual Meetings Annual Statements
Antitrust Competition Laws Appendix
Appointment Independent Registered Public Accounting Firm Attachments
Audit Committee Audit Fees
Audit Non-audit Fees Audit-related Fees
Authority Available Information
Award B-other Information
B-unresolved Staff Comments Background
Background Developments 2005 Background Statement
Backlog Base Salary
Basis Consolidation Basis Presentation
Because Sell Products Internationally Adversely Affected Fluctuations Foreign Been Future Subject Intellectual Property Rights Infringement Claims
Beneficial Ownership Reporting Compliance Beneficiary
Benefits Bioarray
Bioarray Acquisition Blood Bank Automation
Blood Bank Automation-we Board Consideration
Board Directors Recommends Vote Following Proposals Board Meetings Committees
Boardofdirectorsimmucorcom Bonus Accrual
Bonus Award Determination Bonus Plan
Building Business
Business Combination Business Combinations
Business Concentrated North America Current New Competitors Increase Business Concentrated North America Order Continue Successfully Grow
Business Outlook Business Records
Bylaws Immucor Inc Calculation Share Amounts
Cam Operating Expenses Increases Cancellation Group Purchasing Contracts
Cannot Predict Outcome Pending Governmental Investigations Other Legal Capitalization Ownership
Capture Workstation Capture Workstation Semi-automated Processor -the
Cash Equivalents Cash Equivalents-
Cash Flow Catastrophic Event Norcross Georgia Facility Prevent Producing Reagent
Cause Certain Confirmations Regarding Stock Ownership Options
Certain Effects Certain Nomination Requirements
Certain Relationships Related Transactions Certain Relationships Related Transactions Director Independence
Certain Rules Certificate Executed Subsequent Original Execution Lease Required Requested
Certificate Meeting Requirements Treasury Regulation 11445-2 Certificate Referred
Certification Pursuant Usc 1350 Adopted 906 Sarbanes-oxley Act Cfo Resign Family Reasons
Chairman Board Change Control
Change Control Provisions Changed Since Last Report
Changes Disagreements Accountants Accounting Financial Disclosure Changes Internal Control Over Financial Reporting
Changes Internal Controls Chief Executive Officer
Chief Executive Officer Compensation Chirico
Claims Against Matrix Class-action Lawsuits
Code Code Business Conduct Ethics
Code Ethics Collagen
Commencement Date Certificate Commitments Contingencies
Committee Committees Board Directors
Common Stock Available Issuance Limitation Awards Common Stock Purchase Rights
Comparison 2004 2003 Comparison 2005 2004
Comparison Cumulative Total Return Among Immucor Inc 500 Compensation
Compensation Committee Compensation Committee Interlocks Insider Participation
Compensation Committee Report Compensation Directors
Compensation Discussion Analysis Compensation Philosophy
Competition Comprehensive Income
Concentration Credit Risk Concentration Credit Risk-
Concentration Production Facilities- Conditions Issuance Shares
Conduct Meeting Conduct Meetings
Conference Call Confidentiality
Conflicts Interest Connection On-going Ftc Investigation Seek Impose Remedies Material
Consent Grant Thornton Llp Independent Registered Public Accounting Consent Independent Registered Public Accounting Firm
Consents Required Consolidated Financial Statements
Consolidation Policy Consolidation Policy-
Consolidation Variable Interest Entities Interpretation Accounting Research Bulletin Construction Progress-
Consulting Agreement Contingencies
Contingent Liabilities Contractual Obligations Commercial Commitments
Controls Procedures Convert Standardized Pricing Promote Customer Loyalty
Convert Standardized Pricing Promote Customer Loyalty- Corporate Governance Nominating Committee
Corporate Seal Covered Employee
Criteria Critical Accounting Policies
Current Report Current Report Pursuant Securities Exchange Act 1934
Customer List Deferred Licensing Costs Customer Lists-
Customers Delay Integrating Instruments Blood Banking Operations Operating Customers Delay Integrating Instruments Operations Growth Business Negatively
Customers Delay Integrating Instruments Operations Operating Results Negatively Customers Potential Choose Delay Significant Capital Expenditures Adverse
Declining Global Economic Conditions Material Adverse Impact Results Defective Products Product Liability Recalls
Defense Party Claims Deferral Period
Deferred Costs Deferred Instrument Costs
Deferred Licensing Costs- Deferred Stock
Deferred Stock Awards Definitions
Delegation Delivery
Delivery Stock Departure Directors Certain Officers Election Appointment Compensatory
Departure Directors Principal Officers Election Appointment Departure Directors Principal Officers Election Appointment Certain
Dependent Some Single Source Suppliers Depreciation
Depreciation- Determination
Develop New Enhanced Products Develop New Enhanced Products-
Developments 2006 Developments 2007
Didier Lanson Directions Immucor Inc 2009 Annual Meeting
Director Attendance Annual Meetings Shareholders Director Compensation Table
Directors Director-equivalent Positions Directors Executive Officers Corporate Governance
Directors Executive Officers Registrant Disability
Disclosure Letter Lists Persons Created Material Portion Discretionary Ceo Bonus Pool
Distributions Dividends Dividend Policy
Documents Incorporated Reference Duty Corporation Register Transfer
Early Possession Earning Performance Awards
Earnings Guidance Earnings Per Share
Earnings Per Share- Eatz
Ebitda Edward Gallup
Election Electronic Delivery Future Shareholder Communications
Eligibility Eligible Participants
Employee Plans Employee Was Eligible Receive Bonus
Employees Employees Employment Hereunder Shall Commence 2003 Hereinafter Called
Employees Expected Familiar Comply Separate Policies Giving Receiving Employment
Employment Agreement Employment Agreement Between Immucor Inc Geoffrey Crouse
Employment Contracts Termination Change Control Arrangements Ending 2010
Entry Material Definitive Agreement Environmental
Environmental Matters Equity Compensation Plan Information
Escrow Estimates
Estimates- Evaluation Disclosure Controls Procedures
Events Causing Adjustment Shares Acquirable Exercise Purchase Price Events Causing Exercisability Separate Transferability
Exact Name Registrant Specified Charter Excess Cost Over Net Assets Acquired
Excess Cost Over Net Assets Acquired Other Long-lived Excess Cost Over Net Tangible Assets Acquired Other
Exchange Act Exchange Certificates
Exchange Procedures Exchanges Nonmonetary Assets Amendment Apb Opinion Accounting Transactions
Exclusive Remedies Excuse Code Violations
Executive Compensation Executive Officer Compensation
Executive Officers Exercisability
Exercise Price Exhibits
Exhibits Financial Statement Schedules Existing Anti-takeover Defenses
Explanatory Exposed Product Liability Claims Resulting Products Sell Distribute
External Benchmarks Failure Successfully Complete Acquisitions Integrate Them Existing Operations
Fair Dealing Fair Market Value
Fair Value Financial Instruments Fair Value Financial Instruments-
Fair Value Measurements Fair Value Option Certain Financial Instruments
Fda Administrative Action Material Adverse Effect Business Federal Income Tax Consequences 2005 Plan
Filing Hsr Act Final Determination Price Adjustments Accordance
Financial Guidance Financial Highlights
Financial Information Geographic Areas Financial Performance Highly Dependent Timely Successful Introduction New
Financial Statement Close Process Financial Statements
Financial Statements Exhibits Financial Statements Supplementary Data
Financing Activities Financing Activities-
Fixing Record Date Foreign Corrupt Practices Act Local Non-us Laws
Foreign Currency Foreign Currency Risk
Foreign Currency Translation Foreign Currency Translation-
Forfeiture Form 10-k
Form 10-q Form 10-q United States Securities Exchange Washington 20549
Former Name Address Changed Since Last Report Forward-looking Statements
Ftc Investigation Full Results
Fully Automated Blood Bank System Further Market Penetration Galileo -in
Future Cash Requirements Restrictions Future Subject Intellectual Property Rights Infringement Claims Costly
Galileo Galileo Echo
Galileo Further Market Penetration Galileo Generation Blood Bank System
Gateway Drive Box 5625 Norcross Georgia 30091-5625 General
General Powers Generation Instrument Design Progression
Gifts Gioacchino Chirico
Goodwill Goodwill Intangible Assets Other Long-lived
Goodwill Other Intangible Assets Goodwill-
Government Regulation Delay Prevent New Product Introduction Government Regulation Delay Prevent New Product Introduction Affect
Governmental Authorization Compliance Laws Grant Date
Grants Plan-based Awards Gross Margin
Gross Margin Volatility Gross Margin Volatility Negatively Impact Profitability
Gross Margins Guidance
Held 2008 Held 2009
Hereunder Cease Automatically Employee Shall Only Entitled Compensation Highly Dependent Senior Management Team Other Key Employees
Hiroshi Hoketsu Houston Impairment-
Human Collagen By-product Sales Identifiable Intangible Assets
Immucor Immucor Acquire Bioarray Solutions Ltd
Immucor Announces Management Succession Immucor Announces Record End Results
Immucor Announces Record Results Immucor Announces Record Results Raises 2007 Revenue Net
Immucor Announces Record Revenues Earnings Immucor Announces Results
Immucor Announces Results Record Revenues Raises 2005 Guidance Immucor Announces Results Revises 2006 Guidance
Immucor Appoints Chief Operating Officer Immucor Close Houston Manufacturing Facility
Immucor Engages New Independent Auditors Immucor Inc
Immucor Inc 3130 Gateway Drive Box 5625 Norcross Immucor Inc Adds Director Board
Immucor Inc Adds Outside Director Board Immucor Inc Announces Appointment Chief Financial Officer
Immucor Inc Securities Litigation Immucor Inc Subsidiaries Pro Forma Combined Condensed Consolidated
Immucor Receives Nasdaq Notice Related Delay Filing Form Immucor Reports Nasdaq Notice Related Delay Filing Form
Immucor Responding Ftc Inquiry Immucor Revises 2005 Earnings Account Employee Bonus Accrual
Impact Adoption Sfas 123 Impact Adoption Sfas 123r
Impact Galileo Increased Market Penetration Impact Recently Issued Accounting Standards
Impact Recently Issued Accounting Standards- Implementation Customer Loyalty Program
Implementation New Kiwi Technology Improper Payments
Improved Margins Incentive Bonus
Incentive Compensation 2009 Incentive Compensation 2010
Incentive Stock Option Incentive Stock Options
Income Taxes Income Taxes-
Increase Authorized Capital 120 Shares Increase Instrument Placements-
Increased Competition United States Increased Competition United States Negatively Impact Revenues Profitability
Increased Japanese Market Penetration Increased Manufacturing Efficiencies
Incumbent Board Indemnification Directors
Indemnification Officers Others Independent Registered Public Accounting Firm
Index Index Consolidated Financial Statements
Individual Goals Industry
Industry Market Segment Operate Highly Competitive Not Able Industry Market Segments Operate Highly Competitive Not Able
Information Immucor Please Visit Website Wwwimmucorcom Insider Trading
Inspection Books Records Instructions
Instruments Instruments Instrument Systems
Instruments Produced Single Source Suppliers Insurance
Intellectual Property Interest Expense
Interest Rate Risk Interest Rate Swap
Internal Control Over Financial Reporting Internal Control-integrated Framework
Internal Revenue Code Introduction
Inventories Inventories-
Inventory Inventory Costs-an Amendment Arb Chapter
Investing Activities Investing Activities-
Italian Subsidiary Japanese Acquisition
John Harris Joseph Rosen
Jurisdiction Organization Kode Biotech Limited Technology Licensing Agreement
Labor Relations Laboratory Equipment
Landlords Insurance Costs Term Shall Mean Lanson
Lapse Restrictions Vesting Schedule Launch Galileo Echo-in
Lease Commitments Lease Documents
Leased Assets- Legal Proceedings
Legal Proceedings Involving Named Executive Officers Life Insurance Benefit Employee
Limitations Transferability Limits Repricing Regranting
Limits Repricing Regranting Awards Liquidity Capital Resources
List Long-term Growth Drivers
Long-term Incentive Awards Long-term Incentive Plan
Long-term Incentive Proposal Long-term Incentives
Long-term Investment Other Long-lived Assets Loss Contingencies-
Lost Stolen Destroyed Certificates Managements Annual Report Internal Control Over Financial Reporting
Managements Report Internal Control Over Financial Reporting Manual Testing
Market Risk Marketing Distribution
Material Impairments Matrixs Corporate Minute Books Seal Stock Records
Matters Considered Annual Meetings Maximize Instrument Placements Sell Reagents
Maximize Revenue Stream Per Instrument Placement Maximize Revenue Stream Per Instrument Placement-
Medical Instrument Sales Meeting Directions Please Call 770-441-2051
Mental Incapacity Perform Services Provided Hereunder Extended Period Method Exercise
Minimis Exception Miscellaneous
Monoclonal Antibodies Multireader Plus Microplate Reader Semi-automated Spectra Photometric Microtitration
Name Person Filing Proxy Statement Other Registrant Nature Business
Nature Business- Net Income Earnings Per Share
Net Income Levels Net Sales
Net Sales Relating Foreign Operations- New Parent Corporation
New Pricing Strategies Nine-month Results
Nominees Non-controlling Interests Consolidated Financial Statements
Non-exclusivity Continuing Benefits Non-operating Income
Non-operating Income Expenses Non-transferability Options
Non-transferability Stock Appreciation Rights Nondiscrimination
Nonqualified Stock Options Norcross Georgia 30071
Norcross Georgia 30091-5625 Not Applicable
Not Successful Capitalizing Acquisition Former Distribution Businesses Outside Not Yet Adopted
Notice Notice Annual Meeting Shareholders Held 2006
Notice Annual Meeting Shareholders Held 2007 Notice Meetings
Notification Failure Obtain Pre-approval Number Description
Number Election Term Office Off-balance Sheet Arrangements
Office Upfit Agreement Offices
Ogt Patents On-going Antitrust Investigations Litigation Material Adverse Effect Business
Online Also Help Environment Consenting Receive Electronic Delivery Operating Activities
Operating Activities- Operating Expenses
Operating Results Materially Adversely Impacted Unable Maintain Compliance Option
Option Exercises Stock Vested Option Exercises Stock Vested Table
Option Extend Option Grants
Option Holdings Option Period
Order Continue Successfully Grow Business Expand Sales Products Organization Qualification
Other 162 Provisions Other Commitments
Other Compensation Other Compensation Table
Other Events Other Federal Income Tax Considerations
Other Fees Other Income Expense
Other Information Other Offices
Other Stock-based Cash-based Performance Awards Outside Director Addition
Outstanding Equity Awards Year-end Outstanding Shares
Outstanding Voting Securities Overview
Owner Part
Part Financial Information Participant
Participation Conference Telephone Patents Trademarks
Patents Trademarks Royalties Patrick Waddy
Performance Performance Award
Performance Awards Performance Goals
Performance Graph Performance Measure
Performance Period Performance Share
Performance Shares Units Performance Unit
Period Exercise Permitted Services Independent Registered Public Accounting Firm
Person Place Meetings
Plan Plan Benefits
Plan Otherwise After 2006 Terms Such Option Shall Plan Summary
Policy Pre-approval Independent Registered Public Accounting Firm Political Activities
Poor Product Performance Increase Operating Costs Result Loss Potential Anti-takeover Other Effects Proposed Amendment
Potential Labor Cost Savings Potential Payments Termination Change-in-control
Pre-acquisition Contingencies Pre-approval Procedures
Pre-approval Requirements Preferred Stock Waivers
Preliminary Purchase Price Allocation Prepaid Expenses Other Current Assets
Preparation Information Statement Majority Stockholders Consent President
Presiding Officer Primary Objectives
Primary Obligations Principal Accountant Fees Services
Principal Office Pro Forma Financial Information
Pro Forma Information Sfas 123 Prior Product Quality New Introduction
Products Development Proper Assets
Properties Property Plant Equipment
Property Plant Equipment- Proposal Approval Immucor Inc 2005 Long Term Incentive
Proposal Election Directors Proposal Ratification Appointment Grant Thornton Llp Independent Registered
Proposed Bioarray Acquisition Proprietary Technology Platform
Protection Other Confidential Information Protection Trade Secrets
Provides 2006 Guidance Provisions Applicable Shares Acquired Plan
Proxies Proxy Solicited Behalf Board Directors Revoked Prior
Public Disclosure Purchase Price Allocation
Purpose Scope Qualification Directors
Quantifying Financial Statement Misstatements Quantitative Qualitative Disclosures Market Risk
Quorum Raises 2009 Eps Guidance
Raising 2009 Eps Guidance Ralph Eatz
Reagent Sales Reagents
Real Estate Taxes Reasons Proposed Amendment
Recent Accounting Pronouncements Recent Developments
Recent Fda Market Clearance Biotest Reagents Expected Adversely Recently Issued Accounting Standards
Reclassifications Reclassifications-
Record Date Fixed Redemption Exchange Rights
Registered Office Agent Registered Trademarks
Registrants Telephone Number 770 441-2051 Regular Meetings
Regulation Regulation Disclosure
Regulatory Requirements Related Party Transactions
Remediation Efforts Removal
Removal Directors Rent Due Before
Report Audit Committee Report Compensation Committee
Report Grant Thornton Llp Independent Registered Public Accounting Report Independent Registered Public Accounting Firm
Report Independent Registered Public Accounting Firm Consolidated Financial Report Independent Registered Public Accounting Firm Internal Control
Reporting Accounting Changes Interim Financial Statements-an Amendment Apb Representations Warranties Immucor
Representative Repurchase Obligations Instruments
Required Merger Stockholder Votes Required Vote
Required Vote Recommendation Research Development
Research Development Costs- Reserved Shares
Restricted Stock Restricted Stock Activity
Restricted Stock Awards Restriction Period
Restructuring Expenses Results
Results Operations Results Operations Financial Condition
Retirement Return Materials
Revenue Gross Margin Product Revenue Recognition
Revenue Recognition Billing Processes Revenue Recognition-
Revenues Rights
Rights Corporation Respect Registered Owners Rights Work Product
Risk Factors Risks Relating Industry
Roswell Bowers Rosys Plato Microplate Liquid Handler Sample Processor
Royalty Commitment Technology Rights Rule 16b-3
Rules Regulations Safe Harbor Statement
Sale Long-term Investment Sales Subject Plan Factoring
Sanctions Code Violations Schedule
Secondary Obligations Secretary
Securities Exchange Act 1934 Securities Registered Pursuant Act
Security Security Ownership Certain Beneficial Owners Management Related Stockholder
Segment Geographic Information Selected Condensed Consolidated Balance Sheet
Selected Highlights Selected Product Revenue Gross Margin
Series Certificate Designation Sfas 123r-
Sfas 151- Sfas 153
Sfas 154- Shall Attached Hereto Provided However Amended Schedule Effective
Share Repurchase Share-based Employee Compensation
Shareholder Communications Board Shareholder Meeting Held 2009
Shareholder Proposals Shareholders Equity
Shares Subject Plan Shares Without Certificates
Shipping Handling Charges Shipping Handling Charges Sales Tax-
Shipping Handling Revenues Costs Short-term Investments
Short-term Investments- Signatures
Simplified Method Developing Expected Term Share Options Six-month Results
Sixth Amendment Office Lease Agreement Solid Phase Technology
Special Meetings Special Tax Status Matrix Granted Governmental Entity Applicable
State Georgia Statement Agreement
Statements Contained Press Release Not Historical Fact Forward-looking Stock
Stock Appreciation Rights Stock Option Activity
Stock Options Stock Repurchase Plan
Stock Repurchase Program Stock Repurchased
Stock Repurchases Stock Split
Stock Splits Stock-based Compensation
Stock-based Compensation- Stock-based Employee Compensation
Stock-based Long-term Incentives Strategy
Strategy Long-term Growth Drivers Submission Matters Vote Security Holders
Subsequent Event Subsequent Events
Subsidiaries Subsidiaries Registrant
Subsidiary Corporation Successors
Summary Instrument Orders Summary Lawsuits
Summary Rights Agreement Supervisors Managers Directors
Supervisors Other Europe Managers Directors Supplemental Cash Flow Information
Suppliers Table Contents
Target Bonus Awards Tax Fees
Taxes Tenant Builds
Tenant Improvements Tenant Improvements Builds
Tenants Right Construct Improvements Term
Termination Termination Employment
Terms Conditions Title Class
Title Properties Adequacy Total Compensation
Trade Accounts Receivable Allowance Doubtful Trade Accounts Receivable Allowance Doubtful Accounts-
Trade Accounts Receivables Allowance Doubtful Trade Laws
Trademarks Used Report Traditional Reagents
Transferability Transfers Shares
Treasurer Types Awards
Unable Adequately Protect Proprietary Technology Unforeseen Delays Costs Relating Planned Closure Houston Facility
Unforeseen Product Performance Problems Prevent Selling Affected Products Unforeseen Product Performance Problems Prevent Selling Result Recall
United States Unregistered Sales Equity Securities Proceeds
Updated Guidance Vacancies
Valuation Method Used Assumptions Vesting
Vesting Employees Vice Presidents
Vote Directors Vote Mail
Vote Phone Internet Please Not Mail Proxy Card Vote Required Action
Voting Group Quorum Vote Required Act Voting Shares
Waiver Notice Waivers Code
Washington 20549 Whereas
Whistleblower Protections Witness Whereof
Wwwenvisionreportscom Blud 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki